Effect of 5α-reductase inhibitors on the efficiency of thulium:yttrium-aluminium-garnet (RevoLix®) vaporesection for treating benign prostatic hyperplasia
Purpose: Preoperative use of 5α-reductase inhibitors (5ARIs) may cause fibrosis of the prostate tissue and reduce the efficiency of thulium laser surgery for treating benign prostate hyperplasia (BPH). Thus, we investigated the effects of preoperative 5ARI use in this setting. Materials and Methods:...
Main Authors: | Jae Seung Chung, Won Ik Seo, Cheol Kyu Oh, Seong Cheol Kim, Myung Chan Park, Sang Hyun Park, Jihyeong Yu, Chan Ho Lee, Wansuk Kim, Tae Yong Park, Kweon Sik Min, Jae Il Chung |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Urological Association
2020-01-01
|
Series: | Investigative and Clinical Urology |
Subjects: | |
Online Access: | https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-61-67.pdf |
Similar Items
-
Hysteroscopic myomectomy using a two-micron continuous wave laser (RevoLix)
by: Ching-Hui Chen, et al.
Published: (2013-08-01) -
Thulium laser vaporesection of the prostate: Can we operate without interrupting oral antiplatelet/anticoagulant therapy?
by: Tarik Emre Sener, et al.
Published: (2017-05-01) -
Efficacy of Transurethral Bladder Neck Incision with 2-Micron Continuous Wave Laser (RevoLix) for the Management of Bladder Outlet Stricture in Women
by: Babak Ahadi, et al.
Published: (2013-03-01) -
Thulium laser transurethral vaporesection versus transurethral resection of the prostate for benign prostatic obstruction: the UNBLOCS RCT
by: Jo Worthington, et al.
Published: (2020-09-01) -
Thulium laser ablation for ureteritis cystica
by: Sanjay P Kolte, et al.
Published: (2022-01-01)